https://orcid.org/0000-0003-2181-8250
References
- Ghanbari R, El Mansari M, Blier P. Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Pyschopharmacology. 2011;217(1):61–73.
- Thorpe EL, Pizon AF, Lynch MJ, et al. Bupropion induced serotonin syndrome: a case report. J Med Toxicol. 2010;6(2):168–171.
- Murray B, Carpenter J, Dunkley C, et al. Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol. 2020;16(1):12–16.
- Li M-Y, Yan Q-S, Coffey L, et al. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J Neurochem. 1996;66(2):559–568.
- Silins E, Copeland J, Dillon P. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. Aust N Z J Psychiatry. 2007;41(8):649–655.